SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs acknowledged affair with a person reportedly suspected of ties to Chinese intelligence, and Nvidias board investigation, are driving concern about governance, possible security implications, and leadership risk. Traders are divided between viewing the controversy as a serious overhang and dismissing it as an overreaction or dip-buying opportunity, with no evidence of compromised company secrets cited by the board.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Traders are speculating that Nvidias investigation into its CEOs reported relationship with a suspected Chinese intelligence asset could drive money toward AMD and other chip rivals. Others caution that broader AI-sector volatility and data-center spending concerns remain, and debate whether AMDs sharp rebound can hold.

Ethereum (ETH) is a cryptocurrency . Ethereum has a current supply of 122,200,877.25744775. The last known price of Ethereum is 2,141.49627095 USD and is down -4.09 over the last 24 hours. It is currently trading on 14297 active market(s) with $9,084,277,576.13 traded over the last 24 hours. More information can be found at https://www.ethereum.org/.

Ethereum

Ethereums steep decline amid a broader crypto selloff and reported leveraged-long liquidations is driving attention; traders cite risk-off pressure and possible spillover from tech-market weakness, though the causes are debated. Bearish posts focus on weak price action and further downside, while others are buying the dip and looking for a reversal.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Attention centers on quarterly results and whether BRIUMVIs commercial momentum will hold, with the upcoming subcutaneous formulation readout viewed by many traders as a longer-term catalyst. The community is largely bullish on growth and a possible short squeeze, while some caution that expectations are high; buyout talk remains speculative.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.11892236 USD and is down -3.62 over the last 24 hours. It is currently trading on 1894 active market(s) with $1,884,610,999.15 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

A broad crypto-market selloff has weighed on XRP, with traders focused on its persistent decline and the risk of further losses. The conversation is divided between bearish calls for more downside and holders who see the pullback as a chance to accumulate.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Bridgewater, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Attention centers on Legend Biotechs Q3 call, with traders focused on margins and the outlook after reported CARVYKTI sales growth. The community is also watching for ASH updates on CAR-T programs, while speculation that recent trading signals positive in-vivo data or a potential deal remains unconfirmed.

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Vertex Pharmaceuticals, Inc.

Povetacicepts Nov. 30 FDA decision for IgA nephropathy is the dominant focus, with traders pointing to positive RAINIER Phase 3 results and debating whether the drug could become a major growth engine beyond cystic fibrosis. Q3 results and raised revenue guidance drew a more mixed reaction, including concern about a modest earnings shortfall.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is drawing attention after a sharp rebound from a severe semiconductor selloff, as traders buy beaten-down AI and chip stocks. The community is split on whether the move marks a durable bottom or a relief bounce, with data-center and AI-spending concerns weighing against confidence in long-term chip demand.

KraneShares Trust - KraneShares CSI China Internet ETF

KraneShares CSI China Internet ETF

KWEB is drawing attention amid sharp swings in Chinese internet stocks, as traders speculate that a potential U.S.-China deal could reopen access to Nvidia chips and lift China tech; the rally quickly reversed, leaving debate over whether an oversold rebound is forming or the move was a deal-less pop. Bullish bargain hunters are weighing that possibility against persistent concerns about Chinas market and the ETFs prolonged decline.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit is drawing attention around the FDA decision on ivonescimab plus chemotherapy for EGFR-mutated lung cancer. Traders see a potential catalyst, but debate approval risk because the trial missed statistical significance for overall survival in its primary analysis, despite positive progression-free-survival results and more favorable later survival data; AstraZenecas backing supports the bullish case without resolving the regulatory uncertainty.

statis crypto Watchlist

Bitcoin

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
